Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| artesis_G018 | Other Identifier | artesis university college |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Artesis University College, Antwerp | OTHER |
| FLUIDDA nv | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In this study the invetigators seek an answer on the following hypothesis:
A Multicenter study conducted in university Hospital Antwerp (UZA) and ZNA Middelheim.
Tests are taken before and after one week IPV treatment. IPV is applied for 1 week during the physical therapy treatment of chronic obstructive pulmonary desease (COPD) patients admitted to the hospital for an excarebation. The IPV treatment is an additional treatment upon the standard treatment of the patients. The standard treatment consists out of existing drainage techniques to remove secretion out of the lungs by means of breathing control exercises. Patients are randomized into either the experimental group or the control group. The control group receives a standard physical therapy treatment without additional IPV treatment.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intrapulmonary percussive ventilation | Experimental | IPV is applied for 1 week (once a day) during the physical therapy treatment of the patient |
|
| standard airwy claerance regime | Active Comparator | The standard treatment consists out of existing drainage techniques to remove secretion out of the lungs by means of breathing control exercises |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| intrapulmonary percussive ventilation | Device |
|
| |
| Measure | Description | Time Frame |
|---|---|---|
| Lung function testing | (spirometric , bodybox en diffusion) Performed in the lung function laboratory according to ERS standards using Jaeger 5.1 device vital capacity (VC), FEV1, FEV1/VC, peak expiratory flow (PEF), MMEF 75/25, MEF 50, MEF 25, MIF 50, RV, total lung capacity (TLC), functionale residual capacity (FRC), resistance, spec resistance, TCO, alveolar volume (VA), TCO/VA, Maximal inspiratory pressure, Maximal expiratory pressure | baseline and after one week |
| Measure | Description | Time Frame |
|---|---|---|
| functional respiratory imaging | A 3D CT-scan is take. Images are uploaded into a software program for post processing 3D images are made and images are post processed | at baseline and after one week |
| Measure | Description | Time Frame |
|---|---|---|
| questionnaires | St george Borg MRC | 1 week |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Kris Ides, Msc | Contact | 036418267 | kris.ides@artesis.be |
| Name | Affiliation | Role |
|---|---|---|
| Wilfried De Backer, Phd | UZA pneumology | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospital Antwerp | Recruiting | Edegem | Antwerp | 2650 | Belgium |
Not provided
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| standard treatment |
| Other |
breathing control exercises |
|
|
| D020969 |
| Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |